Santos Agency Inc.
Letter data
- Company
- Santos Agency Inc.
- Recipient
- Santos Agency Inc. | United States
- Issue date
- 2018-04-02
- Posted date
- Not available
- FDA office
- United States
- Subject
- Not available
- Product
- Not available
- CMS ID
- 521298
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Santos Agency Inc.
MARCS-CMS 521298 —
April 02, 2018
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Recipient:
Santos Agency Inc.
United States
Issuing Office:
United States
Office of Human and Animal Foods Division West 5
San Francisco District Office
1431 Harbor Bay Parkway, Alameda, CA 94502
Telephone:
510-337-6700
UNITED PARCEL SERVICE
SIGNATURE REQUIRED
April 02, 2018
Mr. Santos Parmar, Manager
Santo Agency Inc.
1188 Montague Street
San Leandro, CA 94577
Dear Mr. Santos Parmar:
The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter (CMS # 521298), dated April 03, 2017. Based on our evaluation, it appears that you have addressed the violation(s) contained in thisWarning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Sergio Chavez,
Director of Compliancegiant
Content current as of:
04/03/2018